Variation in Risk of Hospital-Onset Clostridium difficile Infection Across -Lactam Antibiotics in Children With New-Onset Acute Lymphoblastic Leukemia | Zendy

Brian T. Fisher | Zendy; Julia Shaklee Sammons | Zendy; Yichen Li | Zendy; Peter de Blank | Zendy; Alix E. Seif | Zendy; Yung-Sung Huang | Zendy; Marko Kavčič | Zendy; Sarah B. Klieger | Zendy; T. B. Harris | Zendy; Kari Torp | Zendy; Douglas Patrick Rheam | Zendy; Ashish H. Shah | Zendy; Richard Aplenc | Zendy

Open Access

Variation in Risk of Hospital-Onset Clostridium difficile Infection Across -Lactam Antibiotics in Children With New-Onset Acute Lymphoblastic Leukemia

Author(s) -

Brian T. Fisher,

Julia Shaklee Sammons,

Yichen Li,

Peter de Blank,

Alix E. Seif,

Yung-Sung Huang,

Marko Kavčič,

Sarah B. Klieger,

T. B. Harris,

Kari Torp,

Douglas Patrick Rheam,

Ashish H. Shah,

Richard Aplenc

Publication year - 2014

Publication title -

journal of the pediatric infectious diseases society

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.269

H-Index - 31

eISSN - 2048-7207

pISSN - 2048-7193

DOI - 10.1093/jpids/piu008

Subject(s) - medicine , cefepime , clostridium difficile , interquartile range , hazard ratio , antibiotics , ceftazidime , cohort , meropenem , pediatrics , confidence interval , antibiotic resistance , microbiology and biotechnology , genetics , imipenem , bacteria , pseudomonas aeruginosa , biology

Antibiotic exposure is common among children with leukemia. However, limited data exist regarding the risk of Clostridium difficile infection (CDI) across anti-pseudomonal β-lactam antibiotics commonly used for fever and neutropenia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research